Orione Charles, Tromeur Cécile, Le Mao Raphael, Le Floch Pierre-Yves, Robin Philippe, Hoffmann Clément, Bressollette Luc, Nonent Michel, Le Roux Pierre-Yves, Salaun Pierre-Yves, Guegan Marie, Poulhazan Elise, Lacut Karine, Leroyer Christophe, Lemarié Catherine A, Couturaud Francis
Département de Médecine Interne et Pneumologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM, FCRIN INNOVTE, Brest, France.
Service de radiologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne Occidentale, CIC INSERM 1412, FCRIN INNOVTE, Brest, France.
Thromb Haemost. 2021 Jul;121(7):955-963. doi: 10.1055/s-0040-1722190. Epub 2021 Jan 14.
We aimed to assess whether high pulmonary vascular obstruction index (PVOI) measured at the time of pulmonary embolism (PE) diagnosis is associated with an increased risk of recurrent venous thromboembolism (VTE).
French prospective cohort of patients with a symptomatic episode of PE diagnosed with spiral computerized tomography pulmonary angiography (CTPA) or ventilation-perfusion (V/Q) lung scan and a follow-up of at least 6 months after anticoagulation discontinuation. PVOI was assessed based on the available diagnostic exam (V/Q lung scan or CTPA). All patients had standardized follow-up and independent clinicians adjudicated all deaths and recurrent VTE events. Main outcome was recurrent VTE after stopping anticoagulation.
A total of 418 patients with PE were included. During a median follow-up period of 3.6 (1.2-6.0) years, 109 recurrences occurred. In multivariate analysis, PVOI ≥ 40% was an independent risk factor for recurrence (hazard ratio 1.77, 95% confidence interval 1.20-2.62, < 0.01), whether PE was provoked by a major transient risk factor or not. A threshold at 41% was identified as the best value associated with the risk of recurrence 6 months after stopping anticoagulation (area under curve = 0.64).
PVOI ≥ 40% at PE diagnosis was an independent risk factor for recurrence VTE. Further prospective validation studies are needed.
我们旨在评估在肺栓塞(PE)诊断时测得的高肺血管阻塞指数(PVOI)是否与复发性静脉血栓栓塞症(VTE)风险增加相关。
对一组有症状性PE发作且通过螺旋计算机断层扫描肺动脉造影(CTPA)或通气-灌注(V/Q)肺扫描确诊的法国患者进行前瞻性队列研究,并在抗凝治疗中断后进行至少6个月的随访。根据可用的诊断检查(V/Q肺扫描或CTPA)评估PVOI。所有患者均接受标准化随访,由独立的临床医生判定所有死亡和复发性VTE事件。主要结局是抗凝治疗停止后的复发性VTE。
共纳入418例PE患者。在中位随访期3.6(1.2 - 6.0)年期间,发生了109次复发。在多变量分析中,无论PE是否由主要短暂风险因素诱发,PVOI≥40%都是复发的独立危险因素(风险比1.77,95%置信区间1.20 - 2.62,P<0.01)。确定41%的阈值为与抗凝治疗停止6个月后复发风险相关的最佳值(曲线下面积 = 0.64)。
PE诊断时PVOI≥40%是复发性VTE的独立危险因素。需要进一步的前瞻性验证研究。